UNITED BIOTECH (P) LTD.
Liposomal Amphotericin B Injection IP 50mg

Liposomal Amphotericin B Injection IP 50mg

Send Inquiry


Product

Adult dose

Pediatric dose

Adjustment in Renal / Hepatic Impaired patients

Ambilip 6mg/kg/day-cryptococcal meningities in HIV. 3-5mg/kg/day in fungal infection
Same as Adults
No

 

Product name

Composition

Indication/s

Strengths

Packing

Ambilip Liposomal Amphotericin B Inj.

Empirical therapy for presumed fungal infectiomin febrile neutropenic patients, Cryptococcal meningitis in HIV infected patients, infections of Aspergillus species, candida species and/or cryptococcus species infection refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate, visceral leishmaniasis.

50mg
1 Vial

 

Product name

Storage

Stability after reconstitution

Prep of solution

Diluent

Ambilip (Liposomal Amphotericin B 50mg vial)
Lyophilized unopened vial should be stored below 25oC Don not freeze & protect from light.
The reconstituted solution should be used within 24hrs & stable at 2o-8o C. Use with 6 hrs. of dilutions with dextrose 5% do not freeze. Add 12ml of sterile Water for injection to each 50mg Amblip vial to yield preparation containing the equivalent of 4 mg/ml amphotericin B. Diluted further to yield a final conc.of 1-2mg/ml.
5% Dextrose